Pedro Santos-Gonzalez

Malaga, AN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: June 24, 2016

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: June 24, 2016

Fibrates therapy: Rational use fenofibrate 2016. Executive summary

Fibrates therapy: Rational use fenofibrate 2016. Executive summary

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: June 08, 2016

The real measurement of non-HDL-cholesterol: Atherogenic cholesterol

The real measurement of non-HDL-cholesterol: Atherogenic cholesterol

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: May 25, 2016

The role of atherogenic dyslipidaemia in clinical practice guidelines

The role of atherogenic dyslipidaemia in clinical practice guidelines

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: November 26, 2015

Alzheimer's like brain changes correlate with low adiponectin plasma levels in type 2 diabetic patients.

Alzheimer's like brain changes correlate with low adiponectin plasma levels in type 2 diabetic patients.

Journal: Journal of diabetes and its complications
Published: October 25, 2015

Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?

Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?

Journal: Revista de neurologia
Published: November 25, 2014

The combinations of statins and fibrates: pharmacokinetic and clinical implications

The combinations of statins and fibrates: pharmacokinetic and clinical implications

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: July 22, 2014

Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study.

Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study.

Journal: Journal of Alzheimer's disease : JAD
Published: July 16, 2014

Structural and functional brain changes in middle-aged type 2 diabetic patients: a cross-sectional study.

Structural and functional brain changes in middle-aged type 2 diabetic patients: a cross-sectional study.

Journal: Journal of Alzheimer's disease : JAD
Published: January 23, 2014

Prevalence of atherogenic dyslipidemia: association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study.

Prevalence of atherogenic dyslipidemia: association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study.

Journal: Atherosclerosis
Published: December 03, 2013

Decalogue of clinical recommendations on atherogenic dyslipidemia

Decalogue of clinical recommendations on atherogenic dyslipidemia

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: November 15, 2013
Showing 1-12 of 15

Last Updated: 09/26/2026